Cytomegalovirus disease after heart transplantation: is acyclovir prophylaxis indicated?

Abstract

To determine the efficacy of acyclovir prophylaxis in preventing cytomegalovirus (CMV) disease after heart transplantation, the clinical course of 103 patients (ages, 0.1 to 62 years; mean age, 41.8 years; 87 males, 16 females) was analyzed. Active CMV infection (defined as a positive culture from any site or a fourfold increase in immunoglobulin G antibody… (More)

Topics

Cite this paper

@article{Elkins1993CytomegalovirusDA, title={Cytomegalovirus disease after heart transplantation: is acyclovir prophylaxis indicated?}, author={C Craig Elkins and William H. Frist and Joachim Dummer and J. R. Stewart and Walter Merrill and Kristin Carden and Heather Bender}, journal={The Annals of thoracic surgery}, year={1993}, volume={56 6}, pages={1267-72; discussion 1272-3} }